Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aerie Pharmaceuticals Inc.

www.aeriepharma.com

Latest From Aerie Pharmaceuticals Inc.

Keeping Track Of CRLs: US FDA Again Faults Bausch + Lomb Manufacturing

A look at recent developments tracked by the Complete Response Letters chart on the Pink Sheet's US FDA Performance Tracker.

Complete Response Letters Regulation

Pipeline Watch: Phase III Starts For Itacitinib And AXS-05

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Inotek Considers Its Options After Another Glaucoma Failure

The eye disease company faces an uncertain future after its only product, trabodenoson, failed in another study in glaucoma.

Clinical Trials Companies

Deals Shaping The Medical Industry, June 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in May 2017.

Deals BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Aerie Pharmaceuticals Inc.
  • Senior Management
  • Vincente, Jr. Anido, PhD , Chmn. & CEO
    Richard J Rubino, CFO
    Casey C Kopczynski, PhD, CSO
    Judith J Robertson, Chief Commercial Officer
    Richard Lewis, MD, CMO
  • Contact Info
  • Aerie Pharmaceuticals Inc.
    Phone: (949) 526-8700
    2030 Main St., Ste. 1500
    Irvine, CA 92614
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register